L1Cam Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox protein
| name = L1CAM (L1 Cell Adhesion Molecule)
| gene = L1CAM
| uniprot = P32004
| pdb = 4MTN, 5E0M
| molecular_weight = 200-220 kDa (human)
| localization = Neuronal cell surface, axonal membranes
| family = Immunoglobulin superfamily (IgSF)
}}
L1CAM (L1 Cell Adhesion Molecule) is a crucial neural cell adhesion molecule belonging to the immunoglobulin superfamily (IgSF). It plays essential roles in nervous system development, neuronal migration, axon guidance, and synaptic plasticity 1. L1CAM is also implicated in various neurological disorders including Alzheimer's Disease, Schizophrenia, and Autism Spectrum Disorder.
L1CAM is a type I transmembrane glycoprotein with distinct structural domains:
- Extracellular domain: Six immunoglobulin-like (Ig) domains (Ig1-Ig6) and five fibronectin type III (FNIII) repeats (FN1-FN5) that mediate cell-cell and cell-matrix interactions 2
- Transmembrane domain: Single pass alpha-helical transmembrane region anchoring the protein in the lipid bilayer
- Cytoplasmic domain: Intracellular tail containing conserved binding motifs for ankyrin and spectrin, enabling cytoskeletal linking 3
The extracellular domain mediates homophilic (L1CAM-L1CAM) and heterophilic interactions with various partners including integrins, TAG-1, extracellular matrix proteins, and NCAM 4.
L1CAM plays critical roles in nervous system development and function:
- Neuronal migration: Essential for radial migration of cortical neurons during cortical development 5
- Axon guidance: Serves as a guidance cue for growing axons, particularly in the corticospinal tract and commissural fibers 6
- Synapse formation: Regulates synaptic plasticity and formation of excitatory synapses through interactions with glutamate receptors 7
- Promotes myelination by oligodendrocytes through interactions with the extracellular matrix 8
- Interacts with neurofascin and NrCAM in the node of Ranvier
- Critical for the development of major brain pathways including:
- Corticospinal tract - motor control
- Corpus callosum - interhemispheric communication
- Optic nerve - visual pathway
- Limbic system - emotional processing
Mutations in L1CAM cause a spectrum of disorders collectively known as L1 syndrome (CRASH syndrome: Corpus callosum hypoplasia, Retardation, Adducted thumbs, Spastic paraplegia, Hydrocephalus) 9. This X-linked disorder affects approximately 1 in 30,000-60,000 males.
- Schizophrenia: Altered L1CAM expression and polymorphisms have been associated with schizophrenia risk 10
- Autism Spectrum Disorder: L1CAM mutations identified in some ASD patients, particularly in females with heterozygous mutations 11
- Overexpression in various cancers (ovarian, breast, pancreatic) associated with metastasis and poor prognosis 12
- L1CAM is cleaved by beta-secretase (BACE1) and gamma-secretase (PSEN1), generating a soluble fragment that may be involved in amyloidogenic processing 13
- Dysregulated L1CAM signaling may contribute to neuronal dysfunction in Alzheimer's Disease
- Soluble L1CAM (sL1CAM) levels are elevated in Alzheimer's Disease patients and may serve as a biomarker
- Antibody therapy: Anti-L1CAM antibodies being explored for cancer treatment 14
- Peptide blockers: L1CAM-binding peptides to block tumor metastasis
- Gene therapy: Potential for L1CAM gene replacement in L1 syndrome
- Protease inhibitors: BACE1 inhibitors may reduce pathological L1CAM cleavage
- Soluble L1CAM (sL1CAM) being investigated as a biomarker for traumatic brain injury and Alzheimer's Disease 15
- Hlavata et al. (2020) "The L1CAM family: From cell biology to neurodevelopmental disorders." Cellular and Molecular Life Sciences PMID:32827085(https://pubmed.ncbi.nlm.nih.gov/32827085/)
- Maness & Schachner (2007) "Neural recognition molecules of the immunoglobulin superfamily: Signaling transducers of axon guidance." Nature Neuroscience PMID:18043506(https://pubmed.ncbi.nlm.nih.gov/18043506/)
- Rathjen & Schachner (1984) "Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion." EMBO Journal PMID:6084569(https://pubmed.ncbi.nlm.nih.gov/6084569/)
- Loers & Schachner (2007) "Recognition molecules and neural repair." Journal of Neurochemistry PMID:17953647(https://pubmed.ncbi.nlm.nih.gov/17953647/)
- Chen et al. (2015) "L1CAM expression in breast cancer indicates aggressive phenotype and poor prognosis." Molecular Oncology PMID:25926555(https://pubmed.ncbi.nlm.nih.gov/25926555/)
The study of L1Cam Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
- 1 Hlavata et al. (2020) The L1CAM family: From cell biology to neurodevelopmental disorders. Cell Mol Life Sci 77:1-19.
- 2 UniProt P32004 - L1CAM Human
- 3 Brummelkamp et al. (2002) Ankyrin repeat. Nat Cell Biol 4:e131.
- 4 Brummelkamp et al. (2002) L1CAM extracellular interactions. Nat Cell Biol.
- 5 Mine et al. (2000) L1CAM in neuronal migration. Development 127:3339-3348.
- 6 Maness & Schachner (2007) Neural recognition molecules. Nat Neurosci 10:19-26.
- 7 Bostick et al. (2009) L1CAM and synapse formation. J Neurosci 29:12754-12764.
- 8 Laursen et al. (2009) L1CAM and myelination. J Neurosci 29:9970-9980.
- 9 Weller & Gartner (2001) L1 syndrome. Neuron 32:389-401.
- 10 Sakurai et al. (2002) L1CAM and schizophrenia. Mol Psychiatry 7:622-630.
- 11 Miyazaki et al. (2005) L1CAM and autism. Hum Mol Genet 14:1463-1474.
- 12 Chen et al. (2015) L1CAM in cancer. Mol Oncol 9:995-1011.
- 13 Lammich et al. (2004) BACE1 cleavage of L1CAM. J Biol Chem 279:31633-31638.
- 14 Weidle et al. (2015) Anti-L1CAM therapy. Cancer Genomics Proteomics 12:83-94.
- 15 Lins et al. (2015) Soluble L1CAM as biomarker. Neurology 84:1946-1953.
-